We are live on
!
Find out more
BCA
Benchmark Capital Advisors Portfolio holdings
AUM
$101M
Turnover
16.91%
1-Year Est. Return
0.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$128M
AUM Growth
-$605K
(-0.47%)
Cap. Flow
-$4.31M
Cap. Flow
% of AUM
-3.36%
Top 10 Holdings %
Top 10 Hldgs %
30.46%
Holding
151
New
9
Increased
24
Reduced
61
Closed
14
Avg Time Held Equity + Options
2.6
years
Top 10 Avg Time Held Equity + Options
1.9
years
Top 20 Avg Time Held Equity + Options
2.2
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
1.9
years
Top 20 Avg Time Held Equity only
2.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$960K |
| 2 |
Medtronic
MDT
|
+$955K |
| 3 |
Walt Disney
DIS
|
+$627K |
| 4 |
CORR
CorEnergy Infrastructure Trust, Inc.
CORR
|
+$603K |
| 5 |
Johnson & Johnson
JNJ
|
+$573K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.23M |
| 2 |
Merck
MRK
|
+$1.04M |
| 3 |
General Motors
GM
|
+$1.02M |
| 4 |
iShares Mortgage Real Estate ETF
REM
|
+$990K |
| 5 |
AbbVie
ABBV
|
+$982K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.53% |
| 2 | Healthcare | 15.93% |
| 3 | Real Estate | 15.05% |
| 4 | Financials | 12.27% |
| 5 | Technology | 12.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
DELISTED
Tsakos Energy Navigation Limited
TNP.PRB.CL
| $260K | 0.2% |
10,300
| – | – |
2013 Q2
18 quarters
|
|
102
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $254K | 0.2% |
3,075
-350
| -10% | -$28.9K |
2014 Q4
12 quarters
|
|
103
McDonald's
MCD
$172B
| $240K | 0.19% |
1,394
+10
| +0.7% | +$1.68K |
2017 Q2
2 quarters
|
|
104
INNOVATE Corp
VATE
$84.7M
| $238K | 0.19% |
4,000
| – | – |
2016 Q3
5 quarters
|
|
105
Invesco Aerospace & Defense ETF
PPA
$7.56B
| $232K | 0.18% |
4,300
-100
| -2% | -$5.28K |
2017 Q2
2 quarters
|
|
|
RDS.A
106
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $220K | 0.17% |
+3,300
| New | +$208K |
2017 Q4
0 quarters
|
|
107
DELISTED
Nuveen Pennsylvania Quality Municipal Income Fund
NQP
| $218K | 0.17% |
16,600
| – | – |
2017 Q2
2 quarters
|
|
108
iShares Core High Dividend ETF
HDV
$15.4B
| $216K | 0.17% |
12,000
| – | – |
2017 Q3
1 quarter
|
|
109
Center Bancorp
CNOB
$1.53B
| $211K | 0.16% |
8,206
| – | – |
2017 Q3
1 quarter
|
|
110
Pembina Pipeline
PBA
$28B
| $210K | 0.16% |
5,800
| – | – |
2017 Q3
1 quarter
|
|
111
iShares Preferred and Income Securities ETF
PFF
$12.1B
| $206K | 0.16% |
5,400
-500
| -8% | -$19.2K |
2017 Q2
2 quarters
|
|
112
iShares Dow Jones US ETF
IYY
$3.03B
| $200K | 0.16% |
+3,000
| New | +$195K |
2017 Q4
0 quarters
|
|
113
Kayne Anderson Energy Infrastructure Fund
KYN
$2.36B
| $198K | 0.15% |
10,370
-3,830
| -27% | -$63K |
2013 Q2
18 quarters
|
|
114
PIMCO Corporate & Income Opportunity Fund
PTY
$2.4B
| $188K | 0.15% |
+11,400
| New | +$190K |
2017 Q4
0 quarters
|
|
115
Celldex Therapeutics
CLDX
$2.27B
| $173K | 0.14% |
4,067
-253
| -6% | -$10.8K |
2015 Q4
8 quarters
|
|
|
TOO
116
DELISTED
Teekay Offshore Partners L.P.
TOO
| $166K | 0.13% |
70,500
-11,000
| -13% | -$26.9K |
2015 Q4
8 quarters
|
|
117
abrdn Asia-Pacific Income Fund
FAX
$530M
| $163K | 0.13% |
5,583
| – | – |
2013 Q2
18 quarters
|
|
118
BioLineRX
BLRX
$10.2M
| $156K | 0.12% |
238
-5
| -2% | -$3.29K |
2014 Q1
15 quarters
|
|
119
Kratos Defense & Security Solutions
KTOS
$7.65B
| $138K | 0.11% |
13,000
| – | – |
2013 Q2
18 quarters
|
|
120
Element Solutions
ESI
$8.66B
| $124K | 0.1% |
12,500
| – | – |
2015 Q4
8 quarters
|
|
|
TRIB
121
Trinity Biotech
TRIB
$6.45M
| $122K | 0.1% |
160
-93
| -37% | -$71.9K |
2013 Q2
18 quarters
|
|
|
STON
122
DELISTED
StoneMor Inc.
STON
| $115K | 0.09% |
+17,500
| New | +$117K |
2017 Q4
0 quarters
|
|
|
BNBX
123
DELISTED
BNB PLUS CORP
BNBX
| – | – |
0
| – | – |
2015 Q2
10 quarters
|
|
124
Global Ship Lease
GSL
$1.51B
| $64K | 0.05% |
6,919
-250
| -3% | -$2.65K |
2014 Q4
12 quarters
|
|
125
Rockwell Medical
RMTI
$32.2M
| $61K | 0.05% |
95
-109
| -53% | -$76.8K |
2015 Q4
8 quarters
|
|
Similar funds
OIMU
7A
JCP
DCM
BCEM
QAM
CFA
BPV
Benchmark Capital Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Benchmark Capital Advisors held 151 positions worth $128M, down 0.47% from $129M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Benchmark Capital Advisors withdrew a net $4.31M in Q4 2017, closing 14 positions and reducing 61 holdings. Its most notable exit was Procter & Gamble, an estimated $1.23M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Real Estate.
Against the trend, Benchmark Capital Advisors opened a new position in Intel worth $1.02M.
- Benchmark Capital Advisors's largest Q4 2017 buy was Intel: 22,000 shares worth $1.02M.
- Benchmark Capital Advisors added most to Walt Disney in Q4 2017, an estimated $627K increase.
- Benchmark Capital Advisors's biggest Q4 2017 reduction was General Motors, cutting an estimated $1.02M.
- Benchmark Capital Advisors fully exited Procter & Gamble in Q4 2017, selling an estimated $1.23M.
- Benchmark Capital Advisors's ten largest holdings make up 30% of its $128M portfolio in Q4 2017.
- Benchmark Capital Advisors opened 9 new positions and closed 14 in Q4 2017.
- Benchmark Capital Advisors's portfolio value fell 0.47% quarter-over-quarter to $128M.
Based on Benchmark Capital Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.